Drug Research
Takeda to Manufacture and Provide 150 Million Doses of Novavax COVID-19 Vaccine Candidate to the Government of Japan
Takeda Pharmaceutical Company Limited announced that the Government of Japan’s Ministry of Health, Labour and Welfare (MHLW) will purchase 150 million doses of Novavax’ vaccine candidate (TAK-019 in Japan) manufactured in Japan by Takeda subject to licensing and approval....
Clinical Trials
LTO Network and Sphereon Partner With Triall for World’s First Application of Blockchain Technology to COVID-19 Clinical Trials
Dutch blockchain companies LTO Network and Sphereon have partnered with Triall, experts in the realm of blockchain and clinical research, to deliver the first COVID-19 clinical trials anchored to blockchain technology.
In a critical first step towards advancing the digital...
Packaging & Labelling
SkyCell partners with All Nippon Airways to support Japanese pharma market
At SkyCell, we have expanded our airline partnerships into Japan by partnering with All Nippon Airways (ANA), the country’s largest airline. This collaboration will not only strengthen our support for pharmaceutical customers shipping in and out of Japan, but...
Packaging & Labelling
Cryoport and Mitsubishi Logistics Corporation Partner to Bring Temperature-Controlled Supply Chain Solutions to Asia-Pacific
Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences including clinical research, pharmaceutical and cell and gene therapy markets, and Mitsubishi Logistics Corporation ("MLC"), Japan's leading pharma logistics company, announced a multi-year...
Drug Research
Pfizer and BioNTech Announce Collaboration With Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America
Pfizer Inc. and BioNTech SE announced the signing of a letter of intent with Eurofarma Laboratórios SA, a Brazilian biopharmaceutical company, to manufacture COMIRNATY (COVID-19 Vaccine, mRNA) for distribution within Latin America.
Eurofarma will perform manufacturing activities within Pfizer’s and...
Press Releases
Cipla and Kemwell Biopharma announce execution of a joint venture agreement for developing, manufacturing and commercialising biosimilars
Cipla Limited, a leading global pharmaceutical company and Kemwell Biopharma Private Limited, a leading biopharmaceutical Contract Development and Manufacturing Organisation (CDMO), announced execution of a joint venture agreement to develop, manufacture and commercialise biosimilars for global markets. For this...
IT & Data Management
CluePoints partners with ZS to provide best-in-class RBQM expertise and technology, increasing clinical trial efficiency and improving patient outcomes
CluePoints, the premier provider of risk-based quality management (RBQM) and data oversight software for clinical trials, has partnered with ZS, a global professional services firm with technology and analytics expertise in biopharma, to offer innovative capabilities in portfolio-level performance...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read